In some studies, SAA levels were increased in COVID-19 patients even in mild/moderate disease, and the increment correlated with disease severity; significant difference in the SAA levels was reported between mild and more severe disease; p < 0.05 (45, 51–55). This evidence concerns the gene SAA1 and COVID-19.